Literature DB >> 3792368

Localization of melanoma with radiolabelled monoclonal antibody fragments and iodoamphetamine.

K Liewendahl, A L Kairento, S Pyrhönen, K Franssila, S Asko-Seljavaara, L Lindroth, P Virkkunen, J Launes.   

Abstract

In two melanoma patients, metastases accumulated both 99mTc-labelled monoclonal anti-tumor F(ab')2 fragments and N-isopropyl-p-(123I)-iodoamphetamine. Small metastatic deposits were localized only by labelled antibody, for which a higher target-to-nontarget ratio was observed than for radioiodoamphetamine, indicating that immunoscintigraphy may be the more sensitive method. In these two patients positive immunohistochemical staining for the antibody used was observed, whereas in a third patient, with no concentration of labelled antibody, the staining result was negative showing the specificity of the immunoscintigraphy findings. It is possible that the accumulation of radio-iodoamphetamine is due to binding to melanin but this is not certain as tissue samples from one of the two patients with positive scintigrams did not contain stainable melanin.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3792368     DOI: 10.1007/bf00263821

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  9 in total

1.  Characterization of monoclonal antibodies to human melanoma-associated antigens.

Authors:  K Imai; A K Ng; S Ferrone
Journal:  J Natl Cancer Inst       Date:  1981-03       Impact factor: 13.506

2.  Biodistribution and dosimetry of N-isopropyl-p-[123I]iodoamphetamine in the primate.

Authors:  B L Holman; R E Zimmerman; J R Schapiro; M L Kaplan; A G Jones; T C Hill
Journal:  J Nucl Med       Date:  1983-10       Impact factor: 10.057

3.  Initial experience with SPECT (single-photon computerized tomography) of the brain using N-isopropyl I-123 p-iodoamphetamine: concise communication.

Authors:  T C Hill; B L Holman; R Lovett; D H O'Leary; D Front; P Magistretti; R E Zimmerman; S Moore; M E Clouse; J L Wu; T H Lin; R M Baldwin
Journal:  J Nucl Med       Date:  1982-03       Impact factor: 10.057

4.  Scintigraphic visualization of human malignant melanoma with N-isopropyl-P-[I-123] iodoamphetamine.

Authors:  M Wada; Y Ichiya; M Katsuragi; Y Kuwabara; Z Ayabe; K Matsuura; Y Takeshita
Journal:  Clin Nucl Med       Date:  1985-06       Impact factor: 7.794

5.  Imaging of melanoma with L-131-labeled monoclonal antibodies.

Authors:  S M Larson; J P Brown; P W Wright; J A Carrasquillo; I Hellström; K E Hellström
Journal:  J Nucl Med       Date:  1983-02       Impact factor: 10.057

6.  The relationship of the eye uptake of N-isopropyl-p-[123I]iodoamphetamine to melanin production.

Authors:  B L Holman; M M Wick; M L Kaplan; T C Hill; R G Lee; J L Wu; T H Lin
Journal:  J Nucl Med       Date:  1984-03       Impact factor: 10.057

7.  Delineation of a transplanted malignant melanoma with indium-111-labeled porphyrin.

Authors:  N Foster; D V Woo; F Kaltovich; J Emrich; C Ljungquist
Journal:  J Nucl Med       Date:  1985-07       Impact factor: 10.057

8.  Improved radioimaging and tumor localization with monoclonal F(ab')2.

Authors:  R L Wahl; C W Parker; G W Philpott
Journal:  J Nucl Med       Date:  1983-04       Impact factor: 10.057

9.  N-isopropyl-[123I] p-iodoamphetamine: single-pass brain uptake and washout; binding to brain synaptosomes; and localization in dog and monkey brain.

Authors:  H S Winchell; W D Horst; L Braun; W H Oldendorf; R Hattner; H Parker
Journal:  J Nucl Med       Date:  1980-10       Impact factor: 10.057

  9 in total
  1 in total

1.  European multicentre study on melanoma immunoscintigraphy by means of 99mTc-labelled monoclonal antibody fragments. The European Multicentre Study Group.

Authors:  A G Siccardi; G L Buraggi; P G Natali; G A Scassellati; G Viale; S Ferrone
Journal:  Eur J Nucl Med       Date:  1990
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.